Supercomputers will take on superbugs in a new venture between pharmaceutical company GSK and UK scientists to use artificial ...
Antivirals have historically made up the bulk of licenses that allow generic companies to copy innovative drugs for poorer countries. Now, GSK’s ViiV Healthcare is adding the world’s first long-acting ...
Patients who suffer from the most common form of lupus have a new treatment option, an AstraZeneca drug that is now the first new therapy for the autoimmune disorder since a GlaxoSmithKline medicine ...
Pharma giant GlaxoSmithKline on Tuesday announced a deal to buy Canadian biotech Bellus Health for $2 billion, betting big on the firm’s cough medicine as it moves to shore up its slender drug ...
GSK PLC on Tuesday said it had struck a deal to acquire asthma drug developer Aiolos Bio for up to $1.4 billion, as the British pharmaceutical giant pushes forward with plans to bolster its ...
Fungi could be considered a forgotten fountain of drug discovery. These microorganisms led to a wave of transformational life-saving medicines still used today as antibiotics, immunosuppressants, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results